Literature DB >> 9300749

Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.

E Chow1, D Payne, T Keane, T Panzarella, M A Izard.   

Abstract

PURPOSE: To test the hypothesis that metastatic cervical lymph nodes arising from nasopharyngeal carcinoma (NPC) are more readily controlled with radiotherapy than comparable nodes from squamous cell carcinomas of other head and neck sites (SCC). METHODS AND MATERIALS: One hundred four NPC patients with metastatic cervical nodes (mean size of the largest node equals 4.1 cm) were randomly selected from radiation treatment files for two time periods, 1969-1976 and 1983-1988, when radiation alone was the first line treatment. Candidate controls were selected randomly from radiation treatment files of node positive squamous cell carcinomas arising from the oropharynx, hypopharynx, oral cavity or larynx who were also treated by radical radiation therapy as sole initial treatment in the 1970s and 1980s. Each NPC case was matched with a control using the size of the largest involved node as the matching criterion. The median follow-up of all 208 patients was 3 years (4.2 years in NPC cases and 1.4 years in the matched controls). For those who were alive at last follow-up, the median follow-up for both arms was 7.7 years (6.7 years in NPC cases and 10.2 years in the matched controls). Nodal control was evaluated by clinical neck examination in both arms. Nodal recurrence was defined as relapse or persistence of metastatic nodal disease from day 1 of radiotherapy treatment.
RESULTS: Despite a similar mean delivered dose to involved neck nodes (52.9 Gy for the NPC group and 53.9 Gy for the matched controls), the SCC group had significantly worse nodal control with radiation when compared to the NPC group (p < 0.0001, relative risk 3.0, 95% [1.8, 5.1]). The 3-year nodal recurrence-free rate among NPC cases was 71 +/- 5%, compared to 43 +/- 5% among matched controls.
CONCLUSION: The result of this study supports the hypothesis that metastatic cervical nodes from NPC are more readily controlled by irradiation than cervical nodes of similar size arising from other head and neck squamous cell carcinomas. Further study is required to explore the reasons for this apparent radiosensitivity.

Entities:  

Mesh:

Year:  1997        PMID: 9300749     DOI: 10.1016/s0360-3016(97)00313-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

2.  Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.

Authors:  Yi Qin; Zhi-Wei Liao; Jing-Yan Luo; Wen-Zhe Wu; An-Shang Lu; Pu-Xia Su; Bing-Quan Lai; Xiao-Xiao Wang
Journal:  Tumour Biol       Date:  2016-01-15

3.  10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.

Authors:  Lei Chen; Yuan Zhang; Shu-Zhen Lai; Wen-Fei Li; Wei-Han Hu; Rui Sun; Li-Zhi Liu; Fan Zhang; Hao Peng; Xiao-Jing Du; Ai-Hua Lin; Ying Sun; Jun Ma
Journal:  Oncologist       Date:  2018-08-06

4.  Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma.

Authors:  Tairo Kashihara; Satoshi Nakamura; Naoya Murakami; Kimiteru Ito; Yoshifumi Matsumoto; Kenya Kobayashi; Go Omura; Taisuke Mori; Yoshitaka Honma; Yuko Kubo; Hiroyuki Okamoto; Kana Takahashi; Koji Inaba; Kae Okuma; Hiroshi Igaki; Yuko Nakayama; Ken Kato; Fumihiko Matsumoto; Seiichi Yoshimoto; Jun Itami
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

5.  3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.

Authors:  Yu-Feng Ren; Yuan-Hong Gao; Xin-Ping Cao; Wei-Jun Ye; Bin S Teh
Journal:  Radiat Oncol       Date:  2010-11-23       Impact factor: 3.481

6.  Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck.

Authors:  Chengrun Du; Hongmei Ying; Youwang Zhang; Yafang Huang; Ruiping Zhai; Chaosu Hu
Journal:  Oncotarget       Date:  2017-06-27

7.  An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.

Authors:  Tsung-Min Hung; Kang-Hsing Fan; Eric Yen-Chao Chen; Chien-Yu Lin; Chung-Jan Kang; Shiang-Fu Huang; Chun-Ta Liao; Shu-Hang Ng; Hung-Ming Wang; Joseph Tung-Chieh Chang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5 to 10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma.

Authors:  Guan Qiao Jin; Jun Yang; Li Dong Liu; Dan Ke Su; Duo Ping Wang; Sheng Fa Zhao; Zhi Ling Liao
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.